Report of the Commission on Intellectual Property Rights, Innovation and Public Health: an industry perspective

scientific article published on 17 May 2006

Report of the Commission on Intellectual Property Rights, Innovation and Public Health: an industry perspective is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2471/BLT.06.032417
P932PMC publication ID2627348
P698PubMed publication ID16710557
P5875ResearchGate publication ID246271923

P2093author name stringEric Noehrenberg
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectintellectual property rightQ108855835
intellectual propertyQ131257
public healthQ189603
P1104number of pages2
P304page(s)419-420
P577publication date2006-05-17
P1433published inBulletin of the World Health OrganizationQ2928049
P1476titleReport of the Commission on Intellectual Property Rights, Innovation and Public Health: an industry perspective
P478volume84

Reverse relations

cites work (P2860)
Q35545912A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries
Q84086534Changing drug markets under new intellectual property regimes: the view from Central America
Q30386831Conceptual and institutional gaps: understanding how the WHO can become a more effective cross-sectoral collaborator
Q37368049Developing global health technology standards: what can other industries teach us?
Q34808796Driving a decade of change: HIV/AIDS, patents and access to medicines for all.
Q57272217Funding global health product R&D: the Portfolio-To-Impact Model (P2I), a new tool for modelling the impact of different research portfolios
Q37370817Intellectual property and access to medicines: an analysis of legislation in Central America
Q35853833Management of intellectual property rights in India: An updated review
Q35767369Obligations of low income countries in ensuring equity in global health financing
Q37086558Synthetic biology: ensuring the greatest global value
Q35843712TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?
Q30377389Three Proposals for Rewarding Novel Health Technologies Benefiting People Living in Poverty. A Comparative Analysis of Prize Funds, Health Impact Funds and a Cost-Effectiveness/Competitive Tender Treaty.

Search more.